Clinical significance of serum procalcitonin in patients with ulcerative colitis

被引:1
作者
Shigeo Koido [1 ]
Toshifumi Ohkusa [1 ]
Kazuki Takakura [1 ]
Shunichi Odahara [1 ]
Shintaro Tsukinaga [1 ]
Toyokazu Yukawa [1 ]
Jimi Mitobe [1 ]
Mikio Kajihara [1 ]
Kan Uchiyama [1 ]
Hiroshi Arakawa [1 ]
Hisao Tajiri [1 ]
机构
[1] Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine,Chiba 277-8567, Japan
关键词
C-reactive protein; Disease activity; Procalcitonin; Severity; Ulcerative colitis;
D O I
暂无
中图分类号
R574.62 [结肠疾病];
学科分类号
1002 ; 100201 ;
摘要
AIM:To investigate the association of procalcitonin(PCT)with ulcerative colitis(UC)activity.METHODS:Serum PCT levels,C-reactive protein(CRP)levels,the erythrocyte sedimentation rate,and the white blood cell count were analyzed in 18 patients with UC and 11 healthy volunteers.Serum PCT levels were analyzed by an electrochemiluminescence immunoassay.Severity assessments were based on Truelove and Witts’severity index.Correlation of serum PCT and CRP levels with UC activity was examined.Moreover,we assessed serum PCT and CRP levels in patients with a Mayo endoscopic subscore.RESULTS:Serum PCT levels in severe UC patients(n=7)(0.096±0.034 ng/mL)were significantly higher than in mild-to-moderate UC patients(n=11)(0.033±0.012 ng/mL)and healthy volunteers(n=11)(0.035±0.005 ng/mL)(P=0.0005 and P<0.0001,respectively).In addition,there was no difference in serum PCT levels between mild-to-moderate UC patients and healthy volunteers.Interestingly,patients with a Mayo endoscopic subscore of 3 points displayed significantly increased levels of serum PCT(0.075±0.043 ng/mL)compared with patients with a subscore of 2 points(0.03±0.011 ng/mL)(P=0.0302).Moreover,CRP levels in patients with severe UC or a Mayo endoscopic subscore of 3 points were not significantly higher than in patients with mild-to-moderate UC or a Mayo endoscopic subscore of 3 points.CONCLUSION:Serum PCT levels were significantly correlated with UC activity.
引用
收藏
页码:8335 / 8341
页数:7
相关论文
共 11 条
  • [1] Additional benefit of procalcitonin to C-reactive protein to assess disease activity and severity in Crohn's disease
    Oussalah, A.
    Laurent, V.
    Bruot, O.
    Gueant, J. -L.
    Regent, D.
    Bigard, M. -A.
    Peyrin-Biroulet, L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (09) : 1135 - 1144
  • [2] Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target[J] . Kenneth L.Becker,RichardSnider,Eric S.Nylen.British Journal of Pharmacology . 2010 (2)
  • [3] Microbes in Gastrointestinal Health and Disease
    Neish, Andrew S.
    [J]. GASTROENTEROLOGY, 2009, 136 (01) : 65 - 80
  • [4] Role of Procalcitonin in Infectious Gastroenteritis and Inflammatory Bowel Disease
    Thia, Kelvin Teck-Joo
    Chan, Edwin Shih-Yen
    Ling, Khoon-Lin
    Ng, Wai-Yoong
    Jacob, Edward
    Ooi, Choon-Jin
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (11) : 2960 - 2968
  • [5] The influence of corticosteroids on the release of novel biomarkers in human endotoxemia
    de Kruif, Martijn D.
    Lemaire, Lucienne C.
    Giebelen, Ida A.
    Struck, Joachim
    Morgenthaler, Nils G.
    Papassotiriou, Jana
    Elliott, Peter J.
    van der Poll, Tom
    [J]. INTENSIVE CARE MEDICINE, 2008, 34 (03) : 518 - 522
  • [6] A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
    D'Haens, Geert
    Sandborn, William J.
    Feagan, Brian G.
    Geboes, Karel
    Hanauer, Stephen B.
    Irvine, E. Jan
    Lemann, Marc
    Marteau, Philippe
    Rutgeerts, Paul
    Scholmerich, Jurgen
    Sutherland, Lloyd R.
    [J]. GASTROENTEROLOGY, 2007, 132 (02) : 763 - 786
  • [7] Serum procalcitonin differentiates inflammatory bowel disease and self‐limited colitis[J] . Klaus R.Herrlinger,RikeDittmann,GuntherWeitz,JanWehkamp,DietherLudwig,MatthiasSchwab,Eduard F.Stange,KlausFellermann.Inflamm Bowel Dis . 2006 (3)
  • [8] Low-dose hydrocortisone during severe sepsis: Effects on microalbuminuria[J] . Simone Rinaldi,Chiara Adembri,Serenèlla Grechi,A Raffaele De Gaudio.Critical Care Medicine . 2006 (9)
  • [9] Evolving diagnostic strategies for inflammatory bowel disease
    Bruining D.H.
    Loftus Jr. E.V.
    [J]. Current Gastroenterology Reports, 2006, 8 (6) : 478 - 485
  • [10] Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody‐associated vasculitis) and invasive bacterial infection[J] . O. K.Eberhard,M.Haubitz,F. M.Brunkhorst,V.Kliem,K. M.Koch,R.Brunkhorst.Arthritis & Rheumatism . 2005 (7)